-+ 0.00%
-+ 0.00%
-+ 0.00%

Protagonist Therapeutics To Join S&P SmallCap 600, Effective Prior To Opening Of Trading On July 3

Benzinga·06/27/2024 21:21:08
Listen to the news

 Protagonist Therapeutics to replace Encore Wire in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 3. S&P Europe 350 constituent Prysmian SpA is acquiring Encore Wire in a deal expected to be completed soon pending final conditions.